COMBINED USE OF MELATONIN AND METHYLPHENIDE TO TREAT ATTENTION / HYPERACTIVITY DISORDERS.

摘要

The present invention relates to the combined use of methyl phenidate and at least one of melatonin, a melatonin analogue, or a pharmaceutically acceptable salt thereof in the treatment of attention deficit hyperactive disorder (ADHD). Methylphenidate and melatonin or its analogue may be used together or in combination with one or more other active ingredients, and is preferably formulated as a composition for controlled release.